Selected August Publications from BIDMC Faculty
Media Relations mediarelations@bidmc.harvard.edu
SEPTEMBER 02, 2022
Building on our culture of collaboration and innovation, our researchers are helping to transform medicine and health care delivery. Below are selected academic publications issued in August.
Durability of heterologous and homologous COVID-19 vaccine boosts
JAMA Network Open / Original Research / August 10, 2022
BIDMC Authors: C. Sabrina Tan, Ai-ris Y. Collier, Jingyou Yu, Jinyan Liu, Abishek Chandrashekar, Katherine McMahan, Catherine Jacob-Dolan, Xuan He, Marjorie Rowe, Rachel Hemond, Esther A. Bondzie, Kate H. Jaegle, Dan H. Barouch (Center for Virology and Vaccine Research)
Comparison of pregnancy and birth outcomes before vs during the COVID-19 pandemic
JAMA Network Open / Original Research / August 12, 2022
BIDMC Author: Rose L. Molina (Department of Obstetrics and Gynecology)
Repertoire-scale measures of antigen binding
PNAS / Original Research / August 15, 2022
BIDMC Authors: Rohit Arora and Ramy Arnaout (Division of Clinical Pathology)
Appropriate use of intravascular ultrasound during arterial and venous lower extremity interventions
JACC Cardiovascular Interventions / Consensus opinion / August 15, 2022
BIDMC Author: Eric A. Secemsky (Smith Center)
Post-translational control of beige fat biogenesis by PRDM16 stabilization
Nature / Original Research / August 17, 2022
BIDMC Authors: Qiang Wang, Anthony R. P. Verkerke, Zachary H. Taxin, Zhishuai Hou, Fei Li, Jake Wong, Ichitaro Abe, Tadashi Yamamuro, Shingo Kajimura (Division of Endocrinology, Diabetes and Metabolism)
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods
Science Advances / Original Research / August 19, 2022
BIDMC Authors: Daniel H. Katz, Jeremy M. Robbins, Shuliang Deng, Usman A. Tahir, Debby Ngo, Mark D. Benson, Zsu-Zsu Chen, Daniel E. Cruz, Dongxiao Shen, James G. Wilson, Robert E. Gerszten (Division of Cardiovascular Medicine)
Trends in lipid concentrations and lipid control among US adults, 2007-2018
JAMA / Original Research / August 23, 2022
BIDMC Authors: Rahul Aggarwal, Robert W. Yeh, Rishi K. Wadhera (Smith Center)
Administration of anti–SARS-CoV-2 monoclonal antibodies after US food and drug administration deauthorization
JAMA Network Open / Research Letter / August 29, 2022
BIDMC Authors: Timothy S. Anderson, Ashley O’Donoghue, Oren Mechanic, Tenzin Dechen, Jennifer Stevens (Division of General Medicine, Center for Healthcare Delivery Science, Division of Pulmonary, Critical Care and Sleep Medicine)
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.